B
Barbara McCoy
Researcher at Baxter International
Publications - 9
Citations - 530
Barbara McCoy is an academic researcher from Baxter International. The author has contributed to research in topics: Primary immunodeficiency & Recombinant Human Hyaluronidase. The author has an hindex of 3, co-authored 7 publications receiving 492 citations. Previous affiliations of Barbara McCoy include University of Vienna.
Papers
More filters
Journal ArticleDOI
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Marina Karaghiosoff,Hans Neubauer,Caroline Lassnig,Pavel Kovarik,Heike Schindler,Hanspeter Pircher,Barbara McCoy,Christian Bogdan,Thomas Decker,Gottfried Brem,Klaus Pfeffer,Mathias Müller,Mathias Müller +12 more
TL;DR: Tyk2-/- mice are unable to clear vaccinia virus and show a reduced T cell response after LCMV challenge, which imply a selective contribution of Tyk2 to the signals triggered by various biological stimuli and cytokine receptors.
Journal ArticleDOI
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
Richard L. Wasserman,Isaac Melamed,Mark R. Stein,Sudhir Gupta,Jennifer M. Puck,Werner Engl,Heinz Leibl,Barbara McCoy,Victoria G. Empson,David Gelmont,Richard I. Schiff +10 more
TL;DR: In this paper, the authors investigated the efficacy and tolerability of Recombinant Human hyaluronidase (rHuPH20)-facilitated Subcutaneous Immunoglobulin (IGHy) in patients with primary immunodeficiency.
Journal ArticleDOI
Human immunoglobulin (KIOVIG®/GAMMAGARD LIQUID®) for immunodeficiency and autoimmune diseases: an observational cohort study.
Bohumír Blažek,Siraj A Misbah,Pere Soler-Palacin,Barbara McCoy,Heinz Leibl,Werner Engl,Victoria G. Empson,David Gelmont,Nikolai Nikolov +8 more
TL;DR: In this observational study, the efficacy and safety of IVIG 10% in routine clinical practice was similar to that previously reported in clinical studies.
Journal ArticleDOI
Long-Term Efficacy and Safety of Recombinant Human Hyaluronidase (rHuPH20)- Facilitated Subcutaneous Infusion of Immunoglobulin G (IgG) (HyQvia; IGHy) in Patients with Primary Immunodeficiencies (PI)
Richard L. Wasserman,Mark R. Stein,Isaac Melamed,Lisa Kobrynski,Sudhir Gupta,Jennifer M. Puck,Arye Rubinstein,Werner Engl,Barbara McCoy,Heinz Leibl,Leman Yel +10 more